BBOT
BridgeBio Oncology Therapeutics, Inc.
3.30$
-3.2%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | 1.1% | 1.1% | 1.1% | 1.0% | 94.3% | 94.1% | 98.2% | 94.9% | 63.8% | 64.3% | |
| – | – | 1.0% | 1.0% | 0.9% | 0.9% | 17.5% | 20.8% | 84.3% | 83.3% | 12.6% | 14.4% | |
| – | – | 1.0% | 1.0% | 0.9% | 0.9% | 90.6% | 86.9% | 96.6% | 94.9% | 60.4% | 59.9% | |
| – | – | – | – | – | – | 0.0% | 0.7% | 0.0% | 0.1% | 0.0% | – | |
| 115.1% | 119.1% | 3.0% | 2.9% | 2.9% | 2.9% | 233.5% | 250.6% | 7.9% | 8.3% | 10.9% | 14.2% | |
| 115.1% | 119.1% | 0.0% | 0.0% | 0.1% | 0.1% | 16.1% | 18.0% | 7.4% | 7.8% | 10.4% | 13.7% | |
| 30.0% | 21.1% | – | – | – | – | 0.0% | 0.2% | 0.1% | 0.1% | 0.1% | 0.1% | |
| – | – | – | – | – | 1.6% | 2.4% | 1.5% | 0.8% | 0.3% | 2.9% | 1.8% | |
| -15.1% | -19.1% | 97.0% | 97.1% | 97.1% | 97.1% | -133.5% | -150.6% | 92.1% | 91.7% | 89.1% | 85.8% | |
| -32.4% | -26.6% | -1.7% | -1.8% | -1.8% | -1.9% | -163.2% | -180.5% | -65.5% | -79.5% | -95.5% | -120.8% | |
| 13,833.4% | 6,153.6% | 12.5% | 12.4% | 12.2% | 0.0% | 0.3% | 0.0% | 9.0% | 17.8% | 0.0% | 0.0% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.